e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Lung transplantation: update on clinical and experimental issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, S. Seghers, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium)
Source:
Annual Congress 2004 - Lung transplantation: update on clinical and experimental issues
Session:
Lung transplantation: update on clinical and experimental issues
Session type:
Thematic Poster Session
Number:
1148
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, S. Seghers, D. E. Van Raemdonck, G. M. Verleden (Leuven, Belgium). II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up. Eur Respir J 2004; 24: Suppl. 48, 1148
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Related content which might interest you:
12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003
Association between tacrolimus levels in the first fifteen days post lung transplant and rejection during the first year
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Exercise capacity in patients with cystic fibrosis at 6 and 12 months after lung transplantation
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010
Time course of functional recovery after lung transplantation; a one year follow-up
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010
Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
Hepatocyte growth factor (HGF) in lung allografts
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005
KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Characteristics of patients surviving 10 years after lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 349s
Year: 2002
Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD)
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection?
Source: Eur Respir J 2002; 20: 165-169
Year: 2002
Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept